Figure 4.
Identification of 18 biomarkers using LS-MS untargeted metabolomics screening. (A) Relative intensity analysis of the 18 potential biomarkers. Statistical significance between the two groups is marked, *P < 0.05, **P < 0.01, and ***P < 0.001 represent a significant difference in the OVX group versus sham group; #P < 0.05, ##P < 0.01, and ##P < 0.001 represent a significant difference in the BMSCT group versus OVX group. (B) The 18 potential biomarkers that are associated with the anti-osteoporotic effect of BMSCs using OPLS-DA-based ROC curves. BMSCT: bone marrow mesenchymal stem cell transplantation; OPLS-DA: orthogonal partial least squares discriminant analysis; OVX: ovariectomy; LC-MS: liquid chromatography–mass spectrometry.
